{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:02:35Z","timestamp":1793044955558,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacl.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T08:27:37Z","timestamp":1717144057000},"page":"e664-e684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-7936","authenticated-orcid":false,"given":"Anandita","family":"Agarwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-9521","authenticated-orcid":false,"given":"Dave L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Gianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5089-9494","authenticated-orcid":false,"given":"Carol F.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-5084","authenticated-orcid":false,"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3082-6666","authenticated-orcid":false,"given":"Priyanka","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-5997","authenticated-orcid":false,"given":"Kim K.","family":"Birtcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyamvada","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1298-265X","authenticated-orcid":false,"given":"Robert","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmi S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jacl.2024.05.005_bib0001","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026811","article-title":"Trends and outcomes of ST-segment-elevation myocardial infarction among young women in the United States","volume":"12","author":"Abe","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jacl.2024.05.005_bib0003","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.118.037137","article-title":"Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction","volume":"139","author":"Arora","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacl.2024.05.005_bib0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ehjqcco\/qcaa099","article-title":"A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999-2018","volume":"8","author":"Khan","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"11","key":"10.1016\/j.jacl.2024.05.005_bib0005","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jama.2023.2307","article-title":"Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 Years, 2009 to March 2020","volume":"329","author":"Aggarwal","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jacl.2024.05.005_bib0006","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"32","key":"10.1016\/j.jacl.2024.05.005_bib0007","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacl.2024.05.005_bib0008","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0009","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","author":"Grundy","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.jacl.2024.05.005_bib0010","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1093\/eurheartj\/ehad472","article-title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society","volume":"44","author":"Roeters van Lennep","year":"2023","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jacl.2024.05.005_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015123","article-title":"Cardiovascular health among pregnant women, Aged 20 to 44 years, in the United States","volume":"9","author":"Perak","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.jacl.2024.05.005_bib0013","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1161\/CIR.0000000000001124","article-title":"Optimizing prepregnancy cardiovascular health to improve outcomes in pregnant and postpartum individuals and offspring: a scientific statement from the American Heart Association","volume":"147","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2024.05.005_bib0014","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jama.2021.0247","article-title":"Associations of maternal cardiovascular health in pregnancy with offspring cardiovascular health in early adolescence","volume":"325","author":"Perak","year":"2021","journal-title":"JAMA"},{"issue":"7627","key":"10.1016\/j.jacl.2024.05.005_bib0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/bmj.39366.416817.BE","article-title":"Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study","volume":"335","author":"Magnussen","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jacl.2024.05.005_bib0016","first-page":"e1420","article-title":"Association of lipid profile in pregnancy with preeclampsia, gestational diabetes mellitus, and preterm delivery","volume":"9","author":"Ghodke","year":"2017","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0017","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/HYPERTENSIONAHA.116.07099","article-title":"Preconception cardiovascular risk factor differences between gestational hypertension and preeclampsia: cohort norway study","volume":"67","author":"Egeland","year":"2016","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"8","key":"10.1016\/j.jacl.2024.05.005_bib0018","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.05.032","article-title":"Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study","volume":"201","author":"Wiznitzer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/CCLM.2010.033","article-title":"Laboratory reference intervals during pregnancy, delivery and the early postpartum period","volume":"48","author":"Klajnbard","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.05.032","article-title":"Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study","volume":"201","author":"Wiznitzer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"23","key":"10.1016\/j.jacl.2024.05.005_bib0022","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"issue":"6 Suppl","key":"10.1016\/j.jacl.2024.05.005_bib0023","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: Part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0024","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacl.2023.05.099","article-title":"Nutrition interventions for adults with dyslipidemia: a clinical perspective from the national lipid association","volume":"17","author":"Kirkpatrick","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"34","key":"10.1016\/j.jacl.2024.05.005_bib0025","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.05.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacl.2024.05.005_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124305","article-title":"Diet quality assessment and the relationship between diet quality and cardiovascular disease risk","volume":"13","author":"Petersen","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"Suppl_7","key":"10.1016\/j.jacl.2024.05.005_bib0029","doi-asserted-by":"crossref","first-page":"705s","DOI":"10.1093\/ajcn\/nqy216","article-title":"Dietary patterns before and during pregnancy and maternal outcomes: a systematic review","volume":"109","author":"Raghavan","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.jacl.2024.05.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022589","article-title":"Mediterranean-Style diet and risk of preeclampsia by race in the Boston birth Cohort","volume":"11","author":"Minhas","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0031","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1753495X15594082","article-title":"Severe gestational hypertriglyceridemia: a practical approach for clinicians","volume":"8","author":"Wong","year":"2015","journal-title":"Obstet Med"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0032","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacl.2018.04.010","article-title":"Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span","volume":"12","author":"Williams","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0033","unstructured":"U.S. Department of Health and Human Services. (2018). Physical activity guidelines for Americans, 2nd edition. Retrieved from https:\/\/health.gov\/paguidelines\/second-edition\/pdf\/Physical_Activity_Guidelines_2nd_edition.pdf."},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0034","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/AOG.0000000000003772","article-title":"Physical activity and exercise during pregnancy and the postpartum period: ACOG committee opinion, number 804","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.jacl.2024.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/bjsports-2018-100056","article-title":"2019 Canadian guideline for physical activity throughout pregnancy","volume":"52","author":"Mottola","year":"2018","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacl.2024.05.005_bib0036","series-title":"ACSM's Guidelines for Exercise Testing and Prescription","year":"2021"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0037","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1249\/MSS.0000000000001941","article-title":"Benefits of physical activity during pregnancy and postpartum: an umbrella review","volume":"51","author":"Dipietro","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jacl.2024.05.005_bib0038","unstructured":"In: Rasmussen K.M., Yaktine A.L., eds. Weight Gain During Pregnancy: Reexamining the Guidelines. 2009. The National Academies Collection: Reports funded by National Institutes of Health."},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0039","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.AOG.0000425668.87506.4c","article-title":"ACOG Committee opinion no. 548: weight gain during pregnancy","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0040","unstructured":"U.S. Department of Agriculture and U.S. Department of health and human services. Dietary guidelines for Americans, 2020-2025. 9th Edition. 2020. Available at DietaryGuidelines.gov. Acessed October 2, 2023."},{"issue":"10","key":"10.1016\/j.jacl.2024.05.005_bib0041","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/obr.12433","article-title":"Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis","volume":"17","author":"Zomer","year":"2016","journal-title":"Obes Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2024.05.005_bib0042","first-page":"S5","article-title":"The beneficial effects of modest weight loss on cardiovascular risk factors","volume":"21","author":"Van Gaal","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"9","key":"10.1016\/j.jacl.2024.05.005_bib0043","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the american college of cardiology solution set oversight committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0044","doi-asserted-by":"crossref","unstructured":"Aucott L., Gray D., Rothnie H., Thapa M., Waweru C. Effects of lifestyle interventions and long-term weight loss on lipid outcomes - a systematic review. Obes Rev. 2011;12(5):e412-25. doi:10.1111\/j.1467-789X.2010.00819.x","DOI":"10.1111\/j.1467-789X.2010.00819.x"},{"issue":"11","key":"10.1016\/j.jacl.2024.05.005_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029282","article-title":"Role of glucagon-like peptide-1 receptor agonists in achieving weight loss and improving cardiovascular outcomes in people with overweight and obesity","volume":"12","author":"Michos","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0046","first-page":"280","article-title":"First large study of GLP-1 receptor agonists during pregnancy","volume":"331","author":"Harris","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.05.005_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"20","key":"10.1016\/j.jacl.2024.05.005_bib0048","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2020.21749","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US preventive services task force recommendation statement","volume":"324","author":"Force","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0049","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.2022.10951","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without cardiovascular disease risk factors: US preventive services task force recommendation statement","volume":"328","author":"Force","year":"2022","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jacl.2024.05.005_bib0050","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2020.21749","article-title":"Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: US preventive services task force recommendation statement","volume":"324","author":"Krist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.05.005_bib0051","series-title":"Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force [Internet]","author":"O'Connor","year":"2020"},{"key":"10.1016\/j.jacl.2024.05.005_bib0052","first-page":"80","article-title":"(CPG) ECfPG. Corrigendum to \"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"294","author":"Members","year":"2020","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.jacl.2024.05.005_bib0053","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.2021.4230","article-title":"Counseling and behavioral interventions for healthy weight and weight gain in pregnancy: evidence report and systematic review for the US preventive services task force","volume":"325","author":"Cantor","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.05.005_bib0054","article-title":"Strategies for promotion of a healthy lifestyle in clinical settings: pillars of ideal cardiovascular health: a science advisory from the American Heart Association","author":"Kris-Etherton","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.05.005_bib0055","article-title":"Special considerations for healthy lifestyle promotion across the life span in clinical settings: a science advisory from the American Heart Association","author":"Kris-Etherton","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0056","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1\u2013full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"11","key":"10.1016\/j.jacl.2024.05.005_bib0057","article-title":"Omega-3 fatty acid addition during pregnancy","volume":"11","author":"Middleton","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacl.2024.05.005_bib0058","unstructured":"Adminstration TUFD. Information for consumers on using dietary supplements. 2022."},{"key":"10.1016\/j.jacl.2024.05.005_bib0059","unstructured":"Pharmacopeia US. USP verified mark. 2022."},{"issue":"7","key":"10.1016\/j.jacl.2024.05.005_bib0060","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/1471-0528.15647","article-title":"Metabolic syndrome and time to pregnancy: a retrospective study of nulliparous women","volume":"126","author":"Grieger","year":"2019","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0061","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12958-016-0211-8","article-title":"Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review","volume":"14","author":"Palomba","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0062","doi-asserted-by":"crossref","unstructured":"Zahid S., Hashem A., Minhas A.S., et al. Cardiovascular complications during delivery admissions associated with assisted reproductive technology (from a National inpatient sample analysis 2008 to 2019). Am J Cardiol. Jan 1 2023;186:126-134. doi:10.1016\/j.amjcard.2022.08.037","DOI":"10.1016\/j.amjcard.2022.08.037"},{"issue":"9","key":"10.1016\/j.jacl.2024.05.005_bib0063","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamacardio.2023.2324","article-title":"Maternal risk of cardiovascular disease after use of assisted reproductive technologies","volume":"8","author":"Magnus","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.jacl.2024.05.005_bib0064","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14779072.2023.2266355","article-title":"Assisted reproductive technology: what are the cardiovascular risks for women?","volume":"21","author":"Guan","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jacl.2007.11.001","article-title":"Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction","volume":"2","author":"Lee","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0066","series-title":"Endotext","article-title":"Effect of pregnancy on lipid metabolism and lipoprotein levels","author":"Wild","year":"2000"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0067","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00404-017-4558-7","article-title":"Clinical characteristics of acute pancreatitis in pregnancy: experience based on 121 cases","volume":"297","author":"Luo","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jacl.2024.05.005_bib0068","unstructured":"Adminsitration UFD. Pregnancy and lactation labeling (drugs) final rule. 2021."},{"key":"10.1016\/j.jacl.2024.05.005_bib0069","unstructured":"U.S. Food and Drug Administration. Statins: drug safety communication - FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/statins-drug-safety-communication-fda-requests-removal-strongest-warning-against-using-cholesterol [Accessed August 4, 2021]."},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: A systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0071","first-page":"277","article-title":"Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: a retrospective review of 39 pregnancies","volume":"10","author":"Botha","year":"2018","journal-title":"Atherosclerosis"},{"issue":"15","key":"10.1016\/j.jacl.2024.05.005_bib0072","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.110.990929","article-title":"Pregnancy outcomes in familial hypercholesterolemia: a registry-based study","volume":"124","author":"Toleikyte","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0074","doi-asserted-by":"crossref","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0075","article-title":"The role of statins in the prevention of preeclampsia","author":"Smith","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0076","article-title":"Pravastatin in preeclampsia: A meta-analysis and systematic review","volume":"9","author":"M\u00e9sz\u00e1ros","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.jacl.2024.05.005_bib0077","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","article-title":"Pravastatin versus placebo in pregnancies at high risk of term preeclampsia","volume":"144","author":"D\u00f6bert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.05.005_bib0078","unstructured":"Adminsitration UFD. FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins. 2021."},{"key":"10.1016\/j.jacl.2024.05.005_bib0079","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.2147\/DDDT.S184053","article-title":"Transfer of rosuvastatin into breast milk: liquid chromatography-mass spectrometry methodology and clinical recommendations","volume":"12","author":"Lwin","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"16","key":"10.1016\/j.jacl.2024.05.005_bib0080","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1001\/archinte.159.16.1893","article-title":"Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects","volume":"159","author":"Davidson","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2024.05.005_bib0081","series-title":"Antilipemic Agent Bile Acid Sequestrants","author":"Lent-Schochet","year":"2023"},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0082","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1471-0528.13261","article-title":"Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis","volume":"122","author":"Ryckman","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jacl.2024.05.005_bib0083","doi-asserted-by":"crossref","first-page":"17559","DOI":"10.1038\/srep17559","article-title":"Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics","volume":"5","author":"An","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2024.05.005_bib0084","unstructured":"Pharmaceuticals R.. Praluent package insert. 2021."},{"key":"10.1016\/j.jacl.2024.05.005_bib0085","unstructured":"Inc. A. Repatha package insert. 2021."},{"key":"10.1016\/j.jacl.2024.05.005_bib0086","unstructured":"Therapeutics E. Nextelol package insert. 2021."},{"issue":"3","key":"10.1016\/j.jacl.2024.05.005_bib0087","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.aace.2021.01.006","article-title":"Treatment of severe hypertriglyceridemia during pregnancy with high doses of omega-3 fatty acid and plasmapheresis","volume":"7","author":"Nguyen","year":"2021","journal-title":"AACE Clin Case Rep"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0088","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1055\/s-0038-1676832","article-title":"Pregnancies complicated by familial hypertriglyceridemia: a case report","volume":"8","author":"Cao","year":"2018","journal-title":"AJP Rep"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0089","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1345\/aph.1Q626","article-title":"Use of fenofibrate during the first trimester of unplanned pregnancy in a patient with hypertriglyceridemia","volume":"46","author":"Sunman","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"2 Pt 2","key":"10.1016\/j.jacl.2024.05.005_bib0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/AOG.0b013e31820755b5","article-title":"Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate","volume":"117","author":"Whitten","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0091","unstructured":"AbbVie I. Tricor package insert."},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0092","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa1616361","article-title":"NAD deficiency, congenital malformations, and niacin supplementation","volume":"377","author":"Shi","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0093","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cyto.2011.04.003","article-title":"Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis","volume":"55","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0094","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jca.21406","article-title":"Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia","volume":"31","author":"Drouin-Chartier","year":"2016","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1744-9987.2012.01129.x","article-title":"Why an apheresis center should offer more than one lipoprotein apheresis method","volume":"17","author":"Julius","year":"2013","journal-title":"Ther Apher Dial"},{"issue":"24","key":"10.1016\/j.jacl.2024.05.005_bib0096","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.05.005_bib0097","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2016.10.018","article-title":"Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion","volume":"254","author":"Ogura","year":"2016","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.jacl.2024.05.005_bib0098","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11883-021-00957-w","article-title":"Management of hypercholesterolemia in pregnant women with atherosclerotic cardiovascular disease","volume":"23","author":"Thobani","year":"2021","journal-title":"Curr Atheroscler Rep"},{"issue":"14","key":"10.1016\/j.jacl.2024.05.005_bib0099","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2021.02.025","article-title":"Contraception and reproductive planning for women with cardiovascular disease: JACC focus seminar 5\/5","volume":"77","author":"Lindley","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.05.005_bib0100","unstructured":"Hilal-Dandan R. K.B., Brunton L.. Goodman and Gillman's the pharmacological basis of therapeutics. 13 ed2017."},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jacl.2024.05.005_bib0102","first-page":"179","article-title":"Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile","volume":"48","author":"Creasy","year":"2003","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0103","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacl.2024.05.005_bib0104","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jacc.2022.01.010","article-title":"Key questions about familial hypercholesterolemia: JACC review topic of the week","volume":"79","author":"Sniderman","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacl.2024.05.005_bib0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11883-020-00881-5","article-title":"Women living with familial hypercholesterolemia: challenges and considerations surrounding their care","volume":"22","author":"Balla","year":"2020","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2015.09.003","article-title":"Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations","volume":"10","author":"Ahmad","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"17","key":"10.1016\/j.jacl.2024.05.005_bib0107","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/eurheartj\/ehv602","article-title":"Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death","volume":"37","author":"Krogh","year":"2016","journal-title":"Eur Heart J"},{"issue":"3 Suppl","key":"10.1016\/j.jacl.2024.05.005_bib0108","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jacl.2011.03.452","article-title":"Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the national lipid association expert panel on familial Hypercholesterolemia","volume":"5","author":"Hopkins","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"25","key":"10.1016\/j.jacl.2024.05.005_bib0109","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 update on European atherosclerosis society consensus statement on homozygous familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"issue":"Suppl 3","key":"10.1016\/j.jacl.2024.05.005_bib0110","first-page":"59","article-title":"Maternal lipid metabolism and placental lipid transfer","volume":"65","author":"Herrera","year":"2006","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0111","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.atherosclerosis.2006.01.002","article-title":"Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia","volume":"189","author":"Amundsen","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.05.005_bib0112","first-page":"115","article-title":"Maternal uterine vascular lesions in the hypertensive complications of pregnancy","volume":"5","author":"Robertson","year":"1976","journal-title":"Perspect Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0113","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-0032-1305798","article-title":"Pregnancy in a woman with homozygous familial hypercholesterolemia not on low-density lipoprotein apheresis","volume":"2","author":"Fahed","year":"2012","journal-title":"AJP Rep"},{"issue":"9186","key":"10.1016\/j.jacl.2024.05.005_bib0114","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.05.005_bib0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2021.09.003","article-title":"Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia","volume":"335","author":"Klevmoen","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.05.005_bib0116","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.atherosclerosissup.2015.02.024","article-title":"Pregnancy in homozygous familial hypercholesterolemia\u2013Importance of LDL-apheresis","volume":"18","author":"Blaha","year":"2015","journal-title":"Atheroscler Suppl"},{"issue":"7","key":"10.1016\/j.jacl.2024.05.005_bib0117","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003294","article-title":"Systematic review of low-density lipoprotein cholesterol apheresis for the treatment of familial hypercholesterolemia","volume":"5","author":"Wang","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"3 Suppl","key":"10.1016\/j.jacl.2024.05.005_bib0118","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jacl.2011.04.001","article-title":"Hypercholesterolemia NLAEPoF. Management of familial hypercholesterolemias in adult patients: recommendations from the national lipid association expert panel on familial hypercholesterolemia","volume":"5","author":"Ito","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0119","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11883-017-0661-2","article-title":"The role of emerging risk factors in cardiovascular outcomes","volume":"19","author":"Lacey","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2024.05.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2022.01.002","article-title":"Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know","author":"Virani","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0121","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jjcc.2012.09.009","article-title":"The current status of lipoprotein (a) in pregnancy: a literature review","volume":"61","author":"Fanshawe","year":"2013","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0122","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mehy.2004.04.026","article-title":"The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia","volume":"64","author":"Manten","year":"2005","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0123","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/01443615.2019.1603214","article-title":"Correlation of elevated levels of lipoprotein(a), high-density lipoprotein and low-density lipoprotein with severity of preeclampsia: a prospective longitudinal study","volume":"40","author":"Konrad","year":"2020","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.jacl.2024.05.005_bib0124","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3329\/bmrcb.v36i3.7289","article-title":"Lipoprotein (a) level in pre-eclampsia patients","volume":"36","author":"Parvin","year":"2010","journal-title":"Bang Med Res Counc Bull"},{"issue":"3-4","key":"10.1016\/j.jacl.2024.05.005_bib0125","first-page":"173","article-title":"Lipid and lipoprotein profile in physiological pregnancy","volume":"53","author":"Lippi","year":"2007","journal-title":"Clin Lab"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0126","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/jmf.14.2.91.95","article-title":"Changes of plasma lipoprotein(a) during and after normal pregnancy in Caucasians","volume":"14","author":"Manten","year":"2003","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.jacl.2024.05.005_bib0127","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(99)00296-8","article-title":"Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia","volume":"148","author":"Sattar","year":"2000","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1160\/TH04-08-0519","article-title":"Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study","volume":"93","author":"Krause","year":"2005","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.jacl.2024.05.005_bib0129","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Force","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10641950601146574","article-title":"Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction","volume":"26","author":"Manten","year":"2007","journal-title":"Hypertens Pregn"},{"issue":"1","key":"10.1016\/j.jacl.2024.05.005_bib0131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajog.2017.03.032","article-title":"The fourth trimester: a critical transition period with unmet maternal health needs","volume":"217","author":"Tully","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.jacl.2024.05.005_bib0132","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12170-022-00706-x","article-title":"The fourth trimester: a time for enhancing transitions in cardiovascular care","volume":"16","author":"Choi","year":"2022","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"3","key":"10.1016\/j.jacl.2024.05.005_bib0133","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14797\/mdcvj.1101","article-title":"Instituting a curriculum for cardio-obstetrics subspecialty fellowship training","volume":"18","author":"Minhas","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"7","key":"10.1016\/j.jacl.2024.05.005_bib0134","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1161\/CIR.0000000000001212","article-title":"Opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes: a scientific statement from the American Heart Association","volume":"149","author":"Lewey","year":"2024","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jacl.2024.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/heartjnl-2018-313453","article-title":"Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy","volume":"105","author":"Benschop","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2024.05.005_bib0136","first-page":"1","article-title":"Long-term cardio-metabolic effects after gestational diabetes: a review","author":"Burlina","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"11","key":"10.1016\/j.jacl.2024.05.005_bib0137","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10995-019-02768-7","article-title":"Caring for women after hypertensive pregnancies and beyond: implementation and integration of a postpartum transition clinic","volume":"23","author":"Celi","year":"2019","journal-title":"Matern Child Health J"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0138","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jogc.2021.03.006","article-title":"Standardized postpartum follow-up for women with pregnancy complications: barriers to access and perceptions of maternal cardiovascular risk","volume":"43","author":"Chan","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"issue":"14","key":"10.1016\/j.jacl.2024.05.005_bib0139","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2021.02.033","article-title":"Team-based care of women with cardiovascular disease from pre-conception through pregnancy and postpartum: JACC focus seminar 1\/5","volume":"77","author":"Davis","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacl.2024.05.005_bib0140","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jwh.2013.4688","article-title":"Postpartum healthcare after gestational diabetes and hypertension","volume":"23","author":"Ehrenthal","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jacl.2024.05.005_bib0141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcvm.2019.00055","article-title":"Hypertensive disorders of pregnancy and subsequent cardiovascular disease: current national and international guidelines and the need for future research","volume":"6","author":"Gamble","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0142","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cjca.2019.03.008","article-title":"Referral to cardiology following postpartum cardiovascular risk screening at the maternal health clinic in Kingston, Ontario","volume":"35","author":"Gladstone","year":"2019","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.jacl.2024.05.005_bib0143","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacl.2024.05.005_bib0144","first-page":"883","article-title":"Pregnancy-related cardiovascular risk indicators: Primary care approach to postpartum management and prevention of future disease","volume":"65","author":"Graves","year":"2019","journal-title":"Can Fam Phys"},{"issue":"5","key":"10.1016\/j.jacl.2024.05.005_bib0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035507","article-title":"Postpartum lifestyle interventions among women with pre-eclampsia: a scoping review protocol","volume":"10","author":"Haugdahl","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0146","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/AOG.0000000000003363","article-title":"Pregnancy and the postpartum period as an opportunity for cardiovascular risk identification and management","volume":"134","author":"Smith","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jacl.2024.05.005_bib0147","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jacl.2019.10.002","article-title":"Measurement of lipid profiles in the early postpartum period after hypertensive disorders of pregnancy","volume":"13","author":"Wen","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.jacl.2024.05.005_bib0148","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.semperi.2015.05.005","article-title":"Adverse pregnancy outcomes and cardiovascular risk factor management","volume":"39","author":"Mehta","year":"2015","journal-title":"Semin Perinatol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T06:33:26Z","timestamp":1732602806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1933287424001880"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.05.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}